FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 2025873+76.18%
Mar 31, 2024495-182.75%
Mar 31, 2023-599-123.18%
Mar 31, 20222,582+95.39%
Mar 31, 20211,322-84442.76%
Mar 31, 2020-2-100.15%
Mar 31, 20191,062-11.00%
Mar 31, 20181,193-812.48%
Mar 31, 2017-167-117.58%
Mar 31, 2016953+11.58%
Mar 31, 2015854
AI Chat